Rv3696c - p.Gly161Glu
Drug resistance types
2 Sensitive
0 RR-TB
0 HR-TB
0 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
38 Other
lineage Counts
| lineage | Count |
|---|---|
| La1.8.1 | 38 |
| lineage2.2.1 | 1 |
| lineage3 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 40 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR23174083 | Other | La1.8.1 | None | SRR3135072 | Other | La1.8.1 | None | SRR23174099 | Other | La1.8.1 | None | SRR23174109 | Other | La1.8.1 | None | SRR23174097 | Other | La1.8.1 | None | SRR23174084 | Other | La1.8.1 | None | SRR23174107 | Other | La1.8.1 | None | SRR23174460 | Other | La1.8.1 | None | SRR23174091 | Other | La1.8.1 | None | SRR23174096 | Other | La1.8.1 | None | SRR23174487 | Other | La1.8.1 | None | SRR23174103 | Other | La1.8.1 | None | SRR23174554 | Other | La1.8.1 | None | SRR23174461 | Other | La1.8.1 | None | SRR23174113 | Other | La1.8.1 | None | SRR23174104 | Other | La1.8.1 | None | SRR23174499 | Other | La1.8.1 | None | SRR23174111 | Other | La1.8.1 | None | SRR13938830 | Other | La1.8.1 | None | SRR23174272 | Other | La1.8.1 | None | SRR23174098 | Other | La1.8.1 | None | SRR23174089 | Other | La1.8.1 | None | SRR23174110 | Other | La1.8.1 | None | SRR23174100 | Other | La1.8.1 | None | SRR15316593 | Sensitive | lineage2.2.1 | None | ERR751369 | Other | La1.8.1 | pe | SRR23174453 | Other | La1.8.1 | None | SRR23174088 | Other | La1.8.1 | None | SRR23174086 | Other | La1.8.1 | None | SRR23174108 | Other | La1.8.1 | None | SRR23174094 | Other | La1.8.1 | None | SRR23174105 | Other | La1.8.1 | None | SRR23174087 | Other | La1.8.1 | None | SRR23174085 | Other | La1.8.1 | None | SRR23174102 | Other | La1.8.1 | None | SRR23174106 | Other | La1.8.1 | None | SRR23174092 | Other | La1.8.1 | None | SRR23174114 | Other | La1.8.1 | None | SRR23174093 | Other | La1.8.1 | None | SRR21732507 | Sensitive | lineage3 | None |
|---|
